Organization
Alexion Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Alexion Pharmaceuticals, Inc.
... the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, February ...
... such as Amgen and Biogen, and leading biotech companies such as Qiagen, Alexion, Agilent, Waters Co and others. Biopharmaceuticals are therapeutic agents intended to treat ...
... Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results ...
... of the global Soliris® franchise with sales of over $3billion annually. At Alexion, Dr.vanBeek was responsible for the industry-leading launches of Soliris® in two diseases, ...
... in Wednesday’s session are Advanced Micro Devices, Southwest Airlines, International Business Machines, Alexion Pharmaceuticals and Oracle. A day after highflying chip stocks led major indexes ...
... cites similar reasons in issuing a "buy" rating on Discover Financial Services. Alexion Pharmaceuticals – Alexion will work with activist investor Elliott Management on filling ...
... Alexion Pharmaceuticals Inc. will work with hedge fund Elliott Management Corp. to find a ...
... Alexion and activist investor Elliott Management are putting their differences aside. The two ...
... proves activists still have strength in 2018. The hedge fund’s latest victory: Alexion Pharmaceuticals said that it would work with the activist investor on finding ...
... Alexion Pharmaceuticals Inc. said Tuesday it will work with hedge fund Elliott Management Corp. ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) said today that its Board of Directors and Elliott have ...
... Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the 36th Annual ...
... months with an average price target of $65 (27 percent upside). 2) Alexion Pharmaceuticals ( ALXN ) Recommended by: Eric Schmidt from Cowen & Co. ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the Ministry of Health, Labour and Welfare ...
... in a big way at GlaxoSmithKline. Ludwig Hantson followed the trend at Alexion. And Kåre Schultz is in the middle of topping them all at ...
... Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that management will present at the Goldman Sachs ...
... such as Amgen and Biogen, and leading biotechnology companies such as Qiagen, Alexion, Agilent, and Waters. 50 Key Biopharmaceutical and Biotechnology Companies examines such various ...
... four equities in the Biotech space: Amgen Inc. (NASDAQ: AMGN), Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), AnaptysBio Inc. (NASDAQ: ANAB), and Akcea Therapeutics Inc. (NASDAQ: AKCA). ...
... key players developing drugs for the treatment of myasthenia gravis include Alexion Pharmaceuticals, Inc., CSL Behring LLC, Novartis AG and others. Key Topics Covered: 1. ...
... In a ceremony December 12 at the CURE Annual Holiday Party at Alexion in New Haven, the 2017 CURE Entrepreneur of the Year award was ...
... Elliott Management Corp., a stakeholder in Alexion Pharmaceuticals Inc., is pushing the company to take measures aimed at raising its ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today the presentation of comprehensive dose-ranging data from two ...
... NEW HAVEN, Conn. & SAN DIEGO - Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today a collaboration ...
... allow both companies to benefit from the global growth of music streaming.'' Alexion's stock jumped at the market open. Shares in the biotech are up ...
Want to see the full history on Alexion Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial